Structural mechanisms for VMAT2 inhibition by tetrabenazine
The vesicular monoamine transporter 2 (VMAT2) is a proton-dependent antiporter responsible for loading monoamine neurotransmitters into synaptic vesicles. Dysregulation of VMAT2 can lead to several neuropsychiatric disorders including Parkinson’s disease and schizophrenia. Furthermore, drugs such as...
Main Authors: | Michael P Dalton, Mary Hongying Cheng, Ivet Bahar, Jonathan A Coleman |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2024-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/91973 |
Similar Items
-
Re-visiting the trans insertion model for complexin clamping
by: Shyam S Krishnakumar, et al.
Published: (2015-04-01) -
Small molecule inhibitors targeting the cancers
by: Gui‐Hong Liu, et al.
Published: (2022-12-01) -
Oral small molecules for the treatment of atopic dermatitis: a systematic review
by: Pezhman Mobasher, et al.
Published: (2019-08-01) -
Ring-like oligomers of Synaptotagmins and related C2 domain proteins
by: Maria N Zanetti, et al.
Published: (2016-07-01) -
Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis
by: Jianjing Lin, et al.
Published: (2023-03-01)